EMCDDA Home
  • EN
Search

Table GPS-1. Lifetime prevalence of drug use by age and country, most recent national general population survey available since 2000

Part (i) Survey methods.

CountryGeographical areaYearReferenceCollection methodOriginal age rangeOriginal sample sizeAge range all adultsSample size all adultsAge range young adultsSample size young adults
BelgiumNational2008(7)InterviewAll ages1125415–64679215–342550
BulgariaNational2008(3)Interview15–64513915–64513915–342164
Czech RepublicNational2011(8)Interview15+102815–6490115–34361
DenmarkNational2010(6)Interview16+1516516–641161116–343381
GermanyNational2009(8)Multimethod18–64803018–64803018–343876
EstoniaNational2008(3)Mail15–69:15–64140115–34545
IrelandNational2010–11(6)Interview15–64512815–64512815–34:
GreeceNational (except Aegean and Ionian Islands)2004(3)Interview12–64478115–64435115–342620
SpainNational2011(9)Interview15–642212815–642212815–3410507
FranceNational2010(7)Phone15-852765315–642277415–347727
ItalyNational2012(5)Mail18–641889818–641889818–344966
CyprusNational2009(2)Interview15–64338515–64338515–341810
LatviaNational2011(3)Interview15–64449115–64449115–342258
LithuaniaNational2008(2)Interview15–64477715–64477715–342152
Luxembourg::::::::::
HungaryNational2007(3)Interview18–64271018–64271018-341111
MaltaNational2001(1)Interview18–64282818–64175518–34640
NetherlandsNational2009(4)Interview15–64576915–64576915–34:
AustriaNational2008(2)Interview15-93419615–64376115–342558
PolandNational2010(3)Interview15–64578215–64578215–343201
PortugalNational2007(2)Interview15–641220215–641220215–344765
RomaniaNational2010(3)Interview15–64510015–64510015–343108
SloveniaNational2007(1)Interview15+211715–64172415–34691
SlovakiaNational2010(7)Interview15–64405515–64405515–341769
FinlandNational2010(8)Mail/Internet15–69423515–64187315–34875
SwedenNational2008(5)Multimethod15–642209515–642209515–3416271
SwedenNational2011(13)Mail16–84976416-64696416-342035
United KingdomEngland and Wales2011-12(15)Interview16-592666316-592666316-349691
United KingdomNorthern Ireland2010-11(21)Interview15–64253315–64253315-34855
United KingdomScotland2010-11(27)Interview16+823216–64823216–342432
United KingdomUnited Kingdom2006(29):16-59:16–59:16–34:
CroatiaNational2012(1)Interview15–64475615–64475615-341995
TurkeyNational2011(1)Interview15–64804515–64804515-344039
NorwayNational2009(3)Interview15+207315–64162415–34632
 

Notes:

This table presents the methods and results for the last surveys available in each country. The number indicated in the column ‘Ref.’ is the reference to the corresponding survey in the table presenting all surveys available for each country Table GPS-0.

This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

‘Data collection' means 'data collection method used in the survey': 'interview' (face-to-face interview, which may include self-completed sections for the more sensitive questions, also it may include CAPI — computer assisted interviews), 'phone' (telephone interview), 'mail' (mailed questionnaire), 'Multi-method' (Multi-Method — simultaneous use of interview, mail or internet in the same survey).

'Survey sample' refers to the number of actual respondents to the survey (Net sample). In some cases, national surveys cover originally a broader age range ('original age range') than that presented here for the standard groups 'All adults'(15–64) and 'Young adults' (15–34). Sample sizes are presented respectively for the 'original age range', the 'all adults' and 'young adults' groups.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.

For more details on methodological features for each survey, see Table GPS-121.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013